Free Trial

Lixte Biotechnology (LIXTW) Competitors

Lixte Biotechnology logo
$0.03 0.00 (0.00%)
As of 04/25/2025

LIXTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Lixte Biotechnology stock or one of its competitors? The main competitors of Lixte Biotechnology include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Lixte Biotechnology vs.

Lixte Biotechnology (NASDAQ:LIXTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, community ranking, risk and dividends.

In the previous week, Lixte Biotechnology and Lixte Biotechnology both had 1 articles in the media. Lixte Biotechnology's average media sentiment score of 1.89 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Lixte Biotechnology Very Positive
180 Life Sciences Very Positive

Company Net Margins Return on Equity Return on Assets
Lixte BiotechnologyN/A N/A N/A
180 Life Sciences N/A N/A N/A

Lixte Biotechnology and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Lixte BiotechnologyN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lixte BiotechnologyN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Lixte Biotechnology and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Lixte Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIXTW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIXTW vs. The Competition

MetricLixte BiotechnologyBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$120.43M$5.47B$7.82B
Dividend YieldN/A3.69%5.43%4.29%
P/E RatioN/A3.0022.3918.43
Price / SalesN/A4,221.42391.41101.46
Price / CashN/A13.0238.1834.62
Price / BookN/A34.746.684.19
Net IncomeN/A-$90.45M$3.22B$248.05M
7 Day PerformanceN/A4.30%6.25%6.54%
1 Month PerformanceN/A-0.28%-2.81%-2.16%
1 Year PerformanceN/A88.94%16.47%4.71%

Lixte Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIXTW
Lixte Biotechnology
N/A$0.03
flat
N/AN/A$0.00N/A0.004Positive News
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-20.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
-4.5%
N/A-91.1%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.09
+9.6%
N/AN/A$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.11
-14.6%
N/A-57.2%$0.00$489.68M0.004Short Interest ↑
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-70.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.07
+30.5%
N/A-23.5%$0.00$37.32M0.0070Positive News
BTMDW
biote
N/A$0.01
-2.3%
N/A-89.1%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.09
+40.0%
N/A-86.0%$0.00N/A0.008Short Interest ↑
Gap Down
CELUW
Celularity
N/A$0.04
-9.5%
N/A+56.9%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:LIXTW) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners